Ewes were synchronized for estrus using the OvSynch protocol and a dose of LC (20 mg/kg body weight) was intravenously (IV) administered on the same day of PGF 2 injection to one group (n = 8
a lump or swelling in the neck, hoarseness, or trouble swallowing (rare thyroid C-cell concerns)
Priority Applications (6) Applications Claiming Priority (4) Publications (1) Family ID=35462732 Family Applications (1) Country Status (8) Cited By (3) Families Citing this family (23) Citations (3) Family Cites Families (35) 2005 2005-05-26 US US11/139,730 patent/US7235625B2/en not_active Expired - Lifetime 2005-05-27 WO PCT/US2005/018739 patent/WO2005117935A1/en not_active Ceased 2005-05-27 JP JP2007515390A patent/JP2008500369A/en not_active Withdrawn 2005-05-27 CA CA002568218A patent/CA2568218A1/en not_active Abandoned 2005-05-27 BR BRPI0510862-4A patent/BRPI0510862A/en not_active Application Discontinuation 2005-05-27 AU AU2005249474A patent/AU2005249474A1/en not_active Abandoned 2005-05-27 KR KR1020067027495A patent/KR20070036079A/en not_active Withdrawn 2005-05-27 EP EP05761072A patent/EP1755638A4/en not_active Withdrawn
One of the most common factors leading to COPD is a history of smoking, although other particulate matter exposures, chemical exposures, respiratory infections, chronic bronchitis, asthma, and genetic susceptibility can also affect incidence (Yoshida and Tuder, 2007
The best part of my weight loss journey has been actually losing the weight and getting my mind focused on eating healthier
From March 2027, the threshold may shift again to BMI 40 or above with three conditions
